Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau
Kelly R. Jacobs, Chai K. Lim, Kaj Blennow, et al.
Neurobiology of Aging (2019) Vol. 80, pp. 11-20
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 151
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Ebrahim Haroon, James R. Welle, Bobbi J. Woolwine, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 998-1007
Open Access | Times Cited: 140
Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
Masaru Tanaka, Ágnes Szabó, Eleonóra Spekker, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2607-2607
Open Access | Times Cited: 133
The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota
Friedrich Leblhuber, Daniela Ehrlich, Kostja Steiner, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 361-361
Open Access | Times Cited: 109
Peripheral and central kynurenine pathway abnormalities in major depression
Elisabeth Paul, Lilly Schwieler, Sophie Erhardt, et al.
Brain Behavior and Immunity (2022) Vol. 101, pp. 136-145
Open Access | Times Cited: 82
The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies
Suhrud Pathak, Rishi Nadar, Shannon Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 853-853
Open Access | Times Cited: 31
Dysregulation of the Kynurenine Pathway in Relapsing Remitting Multiple Sclerosis and Its Correlations With Progressive Neurodegeneration
Ananda Staats Pires, Shivani Krishnamurthy, Samridhi Sharma, et al.
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 2
Closed Access | Times Cited: 2
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
Rani K. Powers, Rachel Culp‐Hill, Michael P. Ludwig, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 111
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
Masaru Tanaka, Zsuzsanna Bohár, László Vécsei
Molecules (2020) Vol. 25, Iss. 3, pp. 564-564
Open Access | Times Cited: 109
Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
Nóra Török, Masaru Tanaka, László Vécsei
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9338-9338
Open Access | Times Cited: 109
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
Luke Whiley, Katie E. Chappell, Ellie D’Hondt, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 93
Kynurenic acid in neurodegenerative disorders—unique neuroprotection or double‐edged sword?
Aleksandra Ostapiuk, Ewa M. Urbańska
CNS Neuroscience & Therapeutics (2021) Vol. 28, Iss. 1, pp. 19-35
Open Access | Times Cited: 92
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2851-2894
Open Access | Times Cited: 86
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
Katrien Skorobogatov, Livia De Picker, Robert Verkerk, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation
Yuri Milaneschi, Kelly A. Allers, Aartjan T.F. Beekman, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 167-175
Open Access | Times Cited: 59
Can exercise training teach us how to treat Alzheimer’s disease?
Aleksi M. Huuha, Cecilie Skarstad Norevik, José Bianco Nascimento Moreira, et al.
Ageing Research Reviews (2022) Vol. 75, pp. 101559-101559
Open Access | Times Cited: 51
Kynurenine Pathway Metabolites as Biomarkers in Alzheimer’s Disease
Yuqing Liang, Shan Xie, Yanyun He, et al.
Disease Markers (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 45
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis
Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?
Begoña Talavera Andújar, Arnaud Mary, Carmen Venegas, et al.
Environmental Science & Technology (2024)
Open Access | Times Cited: 9
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 9
Kynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients
Marta González‐Sánchez, Javier Jiménez, Arántzazu Narváez, et al.
Biomolecules (2020) Vol. 10, Iss. 4, pp. 571-571
Open Access | Times Cited: 62
Prebiotic and probiotic supplementation and the tryptophan-kynurenine pathway: A systematic review and meta analysis
Terry Purton, Lada Staskova, Melissa M. Lane, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 123, pp. 1-13
Closed Access | Times Cited: 55
The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
Timothy B. Meier, Jonathan Savitz
Biological Psychiatry (2021) Vol. 91, Iss. 5, pp. 449-458
Open Access | Times Cited: 52
Sodium Butyrate and Indole-3-propionic Acid Prevent the Increase of Cytokines and Kynurenine Levels in LPS-induced Human Primary Astrocytes
Michelle Lima Garcez, Vanessa Tan, Benjamin Heng, et al.
International Journal of Tryptophan Research (2020) Vol. 13
Open Access | Times Cited: 51
Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period
Bernadett Tuka, Aliz Nyári, Edina Katalin Cseh, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top